{"version":"1.0","type":"link","title":"Phase I Studies of HLX26, A Novel Anti-LAG-3 Antibody, Monotherapy or Combination Therapy in Patients with Advanced Solid Tumors.","author_name":"Liu R 외","author_url":"https://prs-insight.online/author/Liu%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160989","thumbnail_width":1200,"thumbnail_height":630}